News Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6431 (Published 03 December 2015) Cite this as: BMJ 2015;351:h6431 Article Related content Metrics Responses Peer review Related articles Editorial Safety of new oral anticoagulants Published: 24 April 2015; BMJ 350 doi:10.1136/bmj.h1679 See more Advances in the understanding and management of alcohol-related liver disease BMJ November 20, 2023, 383 e077090; DOI: https://doi.org/10.1136/bmj-2023-077090 Is the US’s Vaccine Adverse Event Reporting System broken? BMJ November 10, 2023, 383 p2582; DOI: https://doi.org/10.1136/bmj.p2582 US expands testing of international air travellers to cover 30 respiratory viruses BMJ November 09, 2023, 383 p2630; DOI: https://doi.org/10.1136/bmj.p2630 The FDA and Moderna’s cosy relationship: how lax rules enable a revolving door culture BMJ November 01, 2023, 383 p2486; DOI: https://doi.org/10.1136/bmj.p2486 Meta is sued by 41 US states for driving children’s addiction to social media and hiding the harms BMJ October 30, 2023, 383 p2518; DOI: https://doi.org/10.1136/bmj.p2518 Cited by... Direct oral anticoagulants versus warfarin: is new always better than the old?Abstract Fulltext PDF Cochrane corner: self-monitoring and self-management of oral anticoagulationAbstract Fulltext PDF Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial FibrillationAbstract Fulltext PDF
